Main > DERMATOLOGY > Endothelin Receptor AntAgonists > BoSentan > NonGeneric BoSentan
NonGeneric BoSentan's subsections
Clinical Status: Phase III (05.04)
Company:
ScleroDerma Digital Ulcers.
NonGeneric BoSentan's products
This section has no products